XML 18 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cephalon and Teva Agreement (Details Textual)
1 Months Ended 6 Months Ended 12 Months Ended 1 Months Ended
Nov. 30, 2012
USD ($)
Oct. 31, 2013
USD ($)
Oct. 31, 2012
USD ($)
Apr. 30, 2013
CAD
Mar. 16, 2011
One Compound [Member]
USD ($)
Mar. 16, 2011
Second Compound [Member]
USD ($)
Royalty Expense       10,000 $ 460,000 $ 880,000
Exercise of Options to One Time Royalty Fee 880,000 880,000        
Deferred Revenue, Revenue Recognized   133,000 237,000      
Deferred Revenue, Period Increase (Decrease)   $ 277,000